Drugs Made In America Acquisition II Corp. Enters Definitive Agreement for Convertible Notes Financing

Drugs Made In America Acquisition II Corp. has entered into a Definitive Investment and Sponsor Transition Agreement with Alpha Multi Family Office for a $1.4 million convertible notes financing. This agreement supersedes prior understandings and outlines the terms of the investment. A portion of the funds, $150,000, has already been received, with an additional $300,000 to be funded by March 30, 2026, and the remaining $950,000 to be funded upon request. The funds will be used for expenses related to the company's initial business combination, including audit, accounting, legal, and filing fees. The agreement also addresses the transition of the sponsor role due to non-performance and legal constraints of the existing sponsor. The investor will have the right to convert the notes into shares of the combined entity at a 35% discount to market value upon completion of the business combination. The company has also issued a second interim convertible note of $300,000, which matures in nine months and can be converted under the same discount terms.